Asaf Danziger's most recent trade in NovoCure Ltd was a trade of 1 Ordinary Shares done at an average price of $11 . Disclosure was reported to the exchange on Dec. 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Asaf Danziger | Director | Grant, award, or other acquisition of securities at price $ 11.00 per share. | 31 Dec 2025 | 1 | 416,474 (0%) | 0% | 11 | 11 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director | Grant, award, or other acquisition of securities at price $ 15.13 per share. | 30 Jun 2025 | 833 | 416,473 (0%) | 0% | 15.1 | 12,603 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 400,000 | 415,640 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Asaf Danziger | Director | Grant, award, or other acquisition of securities at price $ 14.75 per share. | 01 Jan 2025 | 412 | 15,640 (0%) | 0% | 14.7 | 6,076 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 12.24 per share. | 28 Jun 2024 | 1,239 | 15,228 (0%) | 0% | 12.2 | 15,165 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 35.28 per share. | 30 Jun 2023 | 367 | 13,989 (0%) | 0% | 35.3 | 12,948 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 108.00 per share. | 05 Jan 2023 | 187,500 | 13,583 (0%) | 0% | 108 | 20,250,000 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 187,500 | 0 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.15 per share. | 05 Jan 2023 | 187,500 | 201,083 (0%) | 0% | 7.2 | 1,340,625 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 25,000 | 0 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.46 per share. | 05 Jan 2023 | 25,000 | 38,583 (0%) | 0% | 11.5 | 286,500 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 111.23 per share. | 05 Jan 2023 | 8,369 | 30,214 (0%) | 0% | 111.2 | 930,916 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 114.35 per share. | 05 Jan 2023 | 4,568 | 23,646 (0%) | 0% | 114.4 | 522,362 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 115.21 per share. | 05 Jan 2023 | 3,702 | 19,944 (0%) | 0% | 115.2 | 426,512 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 118.47 per share. | 05 Jan 2023 | 2,123 | 15,427 (0%) | 0% | 118.5 | 251,515 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 112.86 per share. | 05 Jan 2023 | 2,000 | 28,214 (0%) | 0% | 112.9 | 225,726 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 116.06 per share. | 05 Jan 2023 | 1,395 | 18,549 (0%) | 0% | 116.1 | 161,906 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 119.35 per share. | 05 Jan 2023 | 1,344 | 14,083 (0%) | 0% | 119.3 | 160,405 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 117.01 per share. | 05 Jan 2023 | 999 | 17,550 (0%) | 0% | 117.0 | 116,894 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 119.99 per share. | 05 Jan 2023 | 500 | 13,583 (0%) | 0% | 120.0 | 59,994 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 62.31 per share. | 05 Jan 2023 | 39 | 13,622 (0%) | 0% | 62.3 | 2,430 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 59.08 per share. | 05 Jul 2022 | 276 | 13,583 (0%) | 0% | 59.1 | 16,305 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 13,470 | 13,470 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 63.81 per share. | 06 Jan 2022 | 31 | 13,307 (0%) | 0% | 63.8 | 1,978 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 102.36 per share. | 26 Nov 2021 | 3,870 | 12,172 (0%) | 0% | 102.4 | 396,133 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 103.37 per share. | 26 Nov 2021 | 1,000 | 13,172 (0%) | 0% | 103.4 | 103,370 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 96.50 per share. | 26 Nov 2021 | 104 | 13,276 (0%) | 0% | 96.5 | 10,036 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 137.12 per share. | 06 Jul 2021 | 118 | 8,302 (0%) | 0% | 137.1 | 16,180 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 196.34 per share. | 13 Apr 2021 | 97,973 | 8,184 (0%) | 0% | 196.3 | 19,236,323 | Ordinary Shares |